Moderna

There are two unique things about this rally in bitcoin. The first is that it’s happening without much retail excitement. The second is that it’s happening almost entirely on its own – unaccompanied by stocks, gold, or other cryptocurrencies. That’s particularly interesting...

Vaccine makers are batting 1000, to borrow a baseball term. So far they’ve gone two for two in terms of positive results, and Wall Street is rounding the bases again early Monday.  Moderna Inc (NASDAQ: MRNA) became the latest company to announce an effective vaccine, kicking off...

Everyone complains about the weather, but no one does anything about it, Mark Twain once quipped. That’s also partly true with COVID-19, at least the part about everyone complaining. The difference is, a lot of people are trying to do something about it, which brings us to coming earnings...

Despite slim chances that the COVID-19 vaccine will see the light of the public day in October, Pfizer Inc. (NYSE: PFE) is getting our hopes up. According to SVB Leerink, a Wall Street firm, even though Moderna Inc (NASDAQ: MRNA) and Pfizer began their trials on the same day, Pfizer's is built...

Layoffs have been rampant since the start of the pandemic and are now reaching some of the countries’ biggest corporations. The US unemployment rate was 8.4% in August, relatively low compared to April’s peak of 14.7%, but well above February’s 3.5%. Just this week Walt Disney Co...

Benzinga has examined the prospects for many investor favorite stocks over the past week. Both bullish and bearish calls in coronavirus vaccine contenders were seen this week. Social media platforms were represented in both categories as well. September has a reputation as a harsh month for the...

The Past Week, In A Nutshell What Happened: Last week ended negative on weakness concentrated in heavily-weighted index constituents. Remember This: “The Fed essentially acknowledged they were a bit behind the curve with their forecast on the economy, as projections needed tweaking to reflect...

The Past Week, In A Nutshell What Happened: Last week ended negative on relative weakness from the technology sector. Remember This: “August benefited from multiple tailwinds, resulting in one of the best Augusts on record. Those tailwinds look stretched and at risk, however,” said Brad...

This weekend's Barron's suggests ways to play U.S.-China tensions and the stock-splitting trend. Other featured articles look at how the election could affect health care stocks and what to expect from big-box retail earnings. Also, the prospects for a pharmaceutical giant, regional bank...

Benzinga has examined the prospects for many investor favorite stocks over the past week. This week's bullish calls included a social media leader and specialty retailers. Big tech stocks and a COVID-19 play were among the week's bearish calls. In another roller-coaster week for the...

The Past Week, In A Nutshell What Happened: Stocks closed the week practically unchanged after mixed reactions to a slew of blow-out earnings results. Remember This: “Although the stock market will certainly experience pullbacks, disappointments and corrections along the way, the horses have...